Technology Industry
Industry: Email Alert RSS FeedUnited Therapeutics Corp
BT Catalyst, Dec, 1999
United Therapeutics Corp. of Research Triangle Park has completed patient enrollment in its second Phase III study of UT-15, its lead compound in development for the treatment of pulmonary hypertension.
- Most Popular Articles in Technology
- An overview of continuous data protection
- Why all those current ratings?
- Many countries now have a mobile penetration rate above 100%, report says
- The Tata Group's big telecom gamble: VSNL's recent acquisition of Tyco ...
- MEASURING BANK BRANCH EFFICIENCY USING DATA ENVELOPMENT ANALYSIS: MANAGERIAL ...
- More »
COPYRIGHT 1999 North Carolina Biotechnology Center
COPYRIGHT 2008 Gale, Cengage Learning